Department of Medicine, University of California Irvine, Orange, CA, USA.
Department of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine, CA, USA.
Cancer Metastasis Rev. 2022 Jun;41(2):261-280. doi: 10.1007/s10555-022-10029-3. Epub 2022 Apr 27.
Therapy for cutaneous melanoma, the deadliest of the skin cancers, is inextricably linked to the immune system. Once thought impossible, cures for metastatic melanoma with immune checkpoint inhibitors have been developed within the last decade and now occur regularly in the clinic. Unfortunately, half of tumors do not respond to checkpoint inhibitors and efforts to further exploit the immune system are needed. Tantalizing associations with immune health and gut microbiome composition suggest we can improve the success rate of immunotherapy. The gut contains over half of the immune cells in our bodies and increasingly, evidence is linking the immune system within our gut to melanoma development and treatment. In this review, we discuss the importance the skin and gut microbiome may play in the development of melanoma. We examine the differences in the microbial populations which inhabit the gut of those who develop melanoma and subsequently respond to immunotherapeutics. We discuss the role of dietary intake on the development and treatment of melanoma. And finally, we review the landscape of published and registered clinical trials therapeutically targeting the microbiome in melanoma through dietary supplements, fecal microbiota transplant, and microbial supplementation.
皮肤黑色素瘤是最致命的皮肤癌之一,其治疗与免疫系统密切相关。在过去十年中,免疫检查点抑制剂已经开发出用于治疗转移性黑色素瘤的方法,并且现在已经在临床上经常使用。不幸的是,一半的肿瘤对检查点抑制剂没有反应,因此需要进一步开发免疫系统。与免疫健康和肠道微生物组组成的诱人关联表明,我们可以提高免疫疗法的成功率。肠道中含有我们体内一半以上的免疫细胞,越来越多的证据表明,我们肠道内的免疫系统与黑色素瘤的发生和治疗有关。在这篇综述中,我们讨论了皮肤和肠道微生物组在黑色素瘤发展中的重要性。我们研究了那些患有黑色素瘤并随后对免疫疗法有反应的人群中,肠道中栖息的微生物种群的差异。我们讨论了饮食摄入对黑色素瘤发展和治疗的作用。最后,我们回顾了通过膳食补充剂、粪便微生物移植和微生物补充剂来靶向黑色素瘤微生物组的已发表和注册临床试验的概况。